Investing

Krystal Biotech : KRYS

KRYS

Stock Data

$266.04

$3.78 (1.44%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Krystal Biotech Inc is a pioneering biotechnology firm based in Pittsburgh, Pennsylvania, focused on developing genetic medicines for rare diseases. The company has made significant strides with its flagship product, VYJUVEK, designed to treat dystrophic epidermolysis bullosa, a severe skin condition. Additionally, Krystal Biotech is advancing a diverse pipeline of treatments targeting conditions such as congenital ichthyosis, netherton syndrome, cystic fibrosis, and aesthetic skin issues, among others, through various stages of clinical trials.

All Krystal Biotech Articles

1 Article

Michael Williams | Mar 29, 2026 at 8:15 AM EDT

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI’s 2026 Performance

SPDR S&P Biotech ETF (NYSEARCA:XBI | XBI Price Prediction) is built around a deceptively simple idea: give every biotech company…